Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$2.78−0.15 (-5.12%)

Close on Nov 13, 2026Market cap $26.02MP/E –Yield –

Adicet Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Adicet Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?